Clinical Trial Update: Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of raltitrexed and S-1 for metastatic colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Raltitrexed (Raltitrexed)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Colon Cancer | Phase 2 | Status: UNKNOWN